Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
7.02
-0.08 (-1.13%)
At close: Jul 2, 2024, 3:53 PM
7.00
-0.02 (-0.28%)
After-hours: Jul 2, 2024, 4:34 PM EDT
Nyxoah Revenue
Nyxoah had revenue of $5.57M in the twelve months ending March 31, 2024, with 78.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.33M with 176.87% year-over-year growth. In the year 2023, Nyxoah had annual revenue of $4.83M with 47.25% growth.
Revenue (ttm)
$5.57M
Revenue Growth
+78.93%
P/S Ratio
43.27
Revenue / Employee
$38,177
Employees
146
Market Cap
241.21M USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.83M | 1.55M | 47.25% |
Dec 31, 2022 | 3.28M | 2.31M | 238.87% |
Dec 31, 2021 | 968.18K | 884.04K | 1,050.60% |
Dec 31, 2020 | 84.15K | - | - |
Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna SA | 1.06B |
AngioDynamics | 324.01M |
Sutro Biopharma | 154.07M |
Aquestive Therapeutics | 51.50M |
Utah Medical Products | 49.04M |
Nanobiotix | 40.23M |
Molecular Partners AG | 7.64M |
NYXH News
- 1 day ago - Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA - GlobeNewsWire
- 4 weeks ago - Nyxoah to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Publication relating to transparency notifications - GlobeNewsWire
- 4 weeks ago - Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares - GlobeNewsWire
- 5 weeks ago - Nyxoah Announces Pricing of Offering - GlobeNewsWire
- 5 weeks ago - Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program - GlobeNewsWire
- 5 weeks ago - Nyxoah Announces Proposed Offering of Ordinary Shares - GlobeNewsWire
- 7 weeks ago - Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 - GlobeNewsWire